Vision Loss In Genetic Diseases Explained By Protein-Protein Interaction

Main Category: Eye Health / Blindness
Also Included In: Genetics
Article Date: 11 May 2009 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

The mystery of genetic disease is only partially solved with the identification of a mutated gene. Often, the pattern of disease - the features or disorders associated with it - vary in type and severity among those who are affected. Scientists, physicians and patients all ask why.

In this week's journal Nature Genetics, an international consortium of researchers, including some from Baylor College of Medicine, provide not only an explanation for the variations of vision loss in people with a host of disorders associated with defective cilia within the cells, but also a blueprint for unraveling similar variations in signs among people with other genetic diseases.

In particular, this report deals with a variant of the gene RPGRIP1L (retinitis pigmentosa GTPase regulator-interacting protein-1 like), a ciliary gene mutated in at least two inherited diseases (Meckel-Gruber and Joubert syndromes). However, the researchers showed that, when people who have similar diseases that are caused by different gene mutations affecting the cilia also have a particular variant of this gene, they also suffer more severe degeneration of the retina - the light-sensing part of the eye - and lose vision.

"When you look at a disorder such as Bardet-Biedl Syndrome with multiple features - extra fingers and toes, retinitis pigmentosa (a vision disorder), asthma, obesity and kidney, you wonder how a single gene can interact or influence the expression of the other 25,000 or so genes that humans have," said Dr. Richard Lewis (http://www.bcm.edu/eye/?PMID=7908), professor of ophthalmology, medicine, pediatrics, and molecular and human genetics at BCM and an author of the report.

In Bardet-Biedl Syndrome, he and his collaborators first identified the fact that it takes three changes in gene copies to cause disease. So far, they have identified most of the 14 different mutated genes associated with the disorder. Most have something to do with the structure or function of cilia, he said.

Cilia are tiny hair-like structures that either move things along inside the cell or help with sensory activities.

"Anything that disrupts this elevator that runs things from one part of a cell to another has an effect on the severity of the disorder," Lewis said. Some mutated genes may alter the structure of the elevator shaft and the movement of the car up and down, but another gene could actually affect the speed at which the elevator moves, said Lewis. If the product of that gene varies also, then it affects the protein interaction and ultimately, the patient's ability to see.

The authors note in their article that this finding highlights the importance of a multifaceted, multidisciplinary approach to discovering genes and proteins that modify these outward or phenotypic effects of genetic disease. These authors meld the talents of clinicians caring for patients and families with gene hunters and scientists working to understand the function of genes and their products in different cells and tissues.

Dr. Richard Gibbs, director of the Baylor College of Medicine Human Genome Sequencing Center, where the sequencing was performed, said, "Sequencing of all the genes underlying the cilia-related proteins is having tremendous impact on our understanding of this class of diseases."

The senior author of the report is Dr. Nicholas Katsanis of Johns Hopkins University and a former BCM trainee.

Other institutions that took part in this research include the University of Michigan at Ann Arbor, Johns Hopkins University School of Medicine in Baltimore, Maryland, McGill University Health Centre in Montreal, Quebec, Canada; Radboud University Nijmegen Medical Centre in The Netherlands; University College London, London, UK; National Eye Institute, Bethesda, Maryland; St, James University Hospital, Leeds, UK; University of Pennsylvania School of Medicine in Philadelphia; RWTH University of Aachen in Germany; and Hopital Necker-Enfants Malades in Paris, France.

Funding for this work came from the National Eye Institute, the National Institute of Child Health and Development, the National Institute of Diabetes, Digestive and Kidney Disorders, the Macular Vision Research Foundation, The Foundation for Fighting Blindness, Le Fonds de la recherché en santé du Quebec, Research to Prevent Blindness, Harold Falls Collegiate Professorship, the Midwest Eye Bank and Transplantation Center, the Searle Scholars Program, the Deutsche Forschungsgeminschaft, the UK Medical Research Council, NIHR Biomedical Research Centre for Ophthalmology and EU-GENORET Grant, the Howard Hughes Medical Institute and the Doris Duke Foundation.

The report is be available at http://www.nature.com/ng/index.html.

Source:
Glenna Picton
Baylor College of Medicine